As the United Kingdom moves towards initiating the Article 50 procedure the implications of the country's departure from the EU for the pharmaceutical and medical device industries could be substantial. Among the most pressing issues are:
- What effect will Brexit have for existing and future marketing authorisations for medicinal products
- How will medical device manufacturers be affected?
- How does the decision affect commercial contracts?
- What are the questions you should consider from an IP perspective?
- Is there anything you should do immediately?
- How can your businesses influence what happens next?
To RSVP for this event please contact: Andrew.firstname.lastname@example.org
Please note places are limited